Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


6th Annual

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


MPN-MDS

EU Focus Meeting

Updating Knowledge & Clinical Practice in 2024


Register / Login to view content


Sana Malhoa Hotel, Lisbon, Portugal

Friday 30 August 2024 - Saturday 31 August 2024

Presentations will be available online for 12 months

Meeting content distributed to 12,000+ HCPs

For more information get in touch!

=

Co-chair

Alessandro M. Vannucchi, MD

University of Florence, Italy

=

Co-chair

Rami Komrokji, MD

Moffitt Cancer Center, Florida

Dear Colleagues and Friends,


We are delighted to have hosted the MPN-MDS EU Focus Meeting 2024, multinational congress at Sana Malhoa Hotel, Lisbon, Portugal on the 30th of August, 2024 to the 31st of August, 2024.


This congress served as a pivotal platform for collaboration, advancing research and enhancing patient care.


For those who could not attend, all congress content is available online and will remain accessible for a full year, allowing healthcare professionals worldwide to benefit from the insights shared.


People stood in a circle, smiling, with a cup of water

Agenda & Faculty

MPN-MDS EU Focus Meeting, Friday 30 August 2024 - Saturday 31 August 2024

08:00

Registration and faculty breakfast

08:45

Opening remarks – Ryan Fitzpatrick, CEO, MD Education

09:00

Leveraging AI and machine learning for Myeloid neoplasms

=

Matteo Della Porta, MD

Humanitas University, Italy

Special Interest Lecture

Session 1: Mutations and Classification of MPN and MDS

09:20

CHIP and thrombosis: where is the link?

=

Tiziano Barbui, MD

Foundation of Clinical Research, Ospedale Papa Giovanni XXIII, Bergamo, Italy

09:40

CHIP and MDS

=

Maria Teresa Voso, MD

University of Rome Tor Vergata, Rome, Italy

10:00

MDS and CCUS Classifications

=

Mrinal S. Patnaik, MD

Mayo Clinic College of Medicine, Rochester, Minnesota

10:20

Panel Discussion

10:40

Coffee Break & Networking

11:00

New Therapies in ET & PV

=

Ruben Mesa, MD

Atrium Health Levine Cancer, Charlotte, North Carolina

Special Interest Lecture

Session 2: Polycythemia Vera (PV)

11:20

Debate: Is Leukocytosis Important in PV?

=

Yes

Heinz Gisslinger, MD

Medical University of Vienna, Austria

=

No

Rajko Kušec, MD

Dubrava University Hospital, Croatia

11:40

Debate Discussion

12:00

Debate: How Real-world Data Inform the Treatment of PV

=

Interferon

Jean-Jacques Kiladjian, MD

Université Paris Cité, France

=

Ruxolitinib

Steffen Koschmieder, MD

University Hospital RWTH Aachen, Aachen, Germany

12:20

Debate Discussion

12:40

Lunch Break, Networking, and Faculty Photo

13:30

Independent Expert Discussion supported by GSK

Session 3: Essential Thrombocytopenia (ET) and Special Situations

14:15

How I Manage Essential Thrombocythemia in 2024: Facts and Fictions

=

Martin Griesshammer, MD

D Ruhr-Universität Bochum, Germany

14:35

Diagnosis and Management of Non-JAK2 Mutated Erythrocytosis

=

Mary Frances McMullin, MD

Queen’s University Belfast, Ireland

14:55

MPN in the Younger

=

Ivana Urošević, MD

Clinical Centre of Vojvodina, Novi Sad, Serbia

15:15

Panel Discussion

15:15

Coffee Break & Networking

Session 4: Myelofibrosis

15:55

How I Treat Low / Intermediate Risk MF in 2024

=

Haifa Kathrin Al-Ali, MD

University Hospital Halle, Germany

16:15

Cytopenic MF at the Frontiers of New Therapies

=

Massimo Breccia, MD

AOU Policlinico Umberto I - Rome, Italy

16:35

Are we Ready for Combination Therapies in MF?

=

Alessandro M. Vannucchi, MD

University of Florence, Italy

16:55

Panel & Debate Discussion

17:15

Adjourn